PanGen Biotech Inc. is a biologics company based in Suwon-si, South Korea, founded in 1999. It develops biosimilar products including EPO, recombinant factor VIII, and G-CSF. The company also supplies CHO cell lines for proteins and monoclonal antibodies, and offers one-stop services from producer cell line development to GMP production. In addition, it provides reagents, quantitation kits, cell-based assay systems, and technology transfer services.